Assessment | Biopsychology | Comparative | Cognitive | Developmental | Language | Individual differences | Personality | Philosophy | Social | Methods | Statistics | Clinical | Educational | Industrial | Professional items | World psychology
Biological: Behavioural genetics · Evolutionary psychology · Neuroanatomy · Neurochemistry · Neuroendocrinology · Neuroscience · Psychoneuroimmunology · Physiological Psychology · Psychopharmacology (Index, Outline)
|
File:Triflupromazine.svg | |
| N,N-dimethyl-3-[2-(trifluoromethyl)- 10H-phenothiazin-10-yl]-propan-1-amine IUPAC name | |
| CAS number 146-54-3 |
ATC code |
| PubChem 5568 |
DrugBank APRD00465 |
| Chemical formula | |
| Molecular weight | 352.418 g/mol |
| Bioavailability | |
| Metabolism | |
| Elimination half-life | |
| Excretion | |
| Pregnancy category | |
| Legal status | |
| Routes of administration | |
- Main article: Phenothiazine derivatives
Triflupromazine is an antipsychotic medication of the phenothiazine class (brandname Vesprin). Among different effects of triflupromazine indication for use of this drug is severe emesis. Due to its potential side effects (triflupromazine has higher risk for side effects than many other antipsychotics) it is not gold standard in antiemetic therapy.
Serious side effects of trifluproamzine can be akathisia and tardive dyskinesia as well as the rare, but potentially fatal, neuroleptic malignant syndrome.
Template:Dopamine antagonists
| This page uses Creative Commons Licensed content from Wikipedia (view authors). |
{{enWP|